The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: risperdal consta     Quarter: 2016Q3

Total Records: 310     Number of Pages: 16

DRUGNAME PT EventCount
RISPERDAL CONSTA Drug dose omission 60
RISPERDAL CONSTA Gynaecomastia 52
RISPERDAL CONSTA Off label use 48
RISPERDAL CONSTA Aggression 45
RISPERDAL CONSTA Product use issue 37
RISPERDAL CONSTA Anxiety 34
RISPERDAL CONSTA Device leakage 29
RISPERDAL CONSTA Hospitalisation 24
RISPERDAL CONSTA Abnormal weight gain 23
RISPERDAL CONSTA Insomnia 22
RISPERDAL CONSTA Device malfunction 18
RISPERDAL CONSTA Weight increased 18
RISPERDAL CONSTA Psychotic disorder 16
RISPERDAL CONSTA Treatment noncompliance 16
RISPERDAL CONSTA Depression 15
RISPERDAL CONSTA Diabetes mellitus 15
RISPERDAL CONSTA Hyperprolactinaemia 15
RISPERDAL CONSTA Obesity 15
RISPERDAL CONSTA Accidental exposure to product 14
RISPERDAL CONSTA Hallucination 12

Total Records: 310     Number of Pages: 16